Evaluation of the quality of care of a haemodialysis public-private partnership programme for patients with end-stage renal disease

被引：0
|
作者：
Julie Y. Chen
Eric Y. F. Wan
Karina H. Y. Chan
Anca K. C. Chan
Frank W. K. Chan
Cindy L. K. Lam
机构：
[1] The University of Hong Kong,Department of Family Medicine and Primary Care
[2] Hong Kong Hospital Authority,Integrated Care Programs, Hospital Authority Head Office
来源：
BMC Nephrology | / 17卷
关键词：
Haemodialysis; End stage renal disease; Community centre; Hospital; Quality of care; Action research; Audit; Shared care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis
    Birmingham, Bruce K.
    Swan, Suzanne K.
    Puchalski, Tom
    Mitchell, Pat
    Azumaya, Connie
    Zalikowski, Julie
    Wang, Yi
    CLINICAL DRUG INVESTIGATION, 2013, 33 (04) : 233 - 241
  • [42] Economic evaluation of sevelamer in patients with end-stage renal disease
    Manns, Braden
    Klarenbach, Scott
    Lee, Helen
    Culleton, Bruce
    Shrive, Fiona
    Tonelli, Marcello
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) : 2867 - 2878
  • [43] Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis
    Kaminski, M.
    Frescos, N.
    Tucker, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (06) : E120 - E128
  • [44] Do Transferrin Levels Predict Haemodialysis Adequacy in Patients with End-Stage Renal Disease?
    Tarantino, Giovanni
    Vinciguerra, Mauro
    Ragosta, Annalisa
    Citro, Vincenzo
    Conforti, Paolo
    Salvati, Giovanni
    Sorrentino, Aniello
    Barretta, Luca
    Balsano, Clara
    Capone, Domenico
    NUTRIENTS, 2019, 11 (05)
  • [45] The Effect Of Haemodialysis On Visual Acuity And Retinal Structure In Patients With End-Stage Renal Disease
    Liew, S.
    James, M.
    Curtin, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 2) : 8 - 8
  • [46] Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis
    Nagashima, S
    Kozawa, O
    Otsuka, T
    Kohno, K
    Minamoto, M
    Yokokawa, M
    Kanamaru, M
    Uematsu, T
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 839 - 842
  • [47] Frailty in Older Patients with End-Stage Renal Disease and Undergoing Chronic Haemodialysis in Vietnam
    Nguyen, Tan Van
    Pham, Thu Thi Xuan
    Burns, Mason Jenner
    Nguyen, Tu Ngoc
    DIABETOLOGY, 2023, 4 (03): : 312 - 322
  • [48] Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis
    Bruce K. Birmingham
    Suzanne K. Swan
    Tom Puchalski
    Pat Mitchell
    Connie Azumaya
    Julie Zalikowski
    Yi Wang
    Clinical Drug Investigation, 2013, 33 : 233 - 241
  • [49] Payment for quality in end-stage renal disease
    Himmelfarb, J
    Pereira, BJG
    Wesson, DE
    Smedberg, PC
    Henrich, WL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12): : 3263 - 3269
  • [50] End-stage renal disease measures of quality
    Himmelfarb, Jonathan
    Kliger, Alan S.
    ANNUAL REVIEW OF MEDICINE, 2007, 58 : 387 - 399
12345